Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association
Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …
increase in the risk for this disease after menopause and typically develop coronary heart …
Management of menopause: a view towards prevention
Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …
50 years of age. It is now appreciated that several important metabolic and cardiovascular …
Efficacy and safety of LDL‐lowering therapy among men and women: meta‐analysis of individual data from 174,000 participants in 27 randomised trials
Cholesterol Treatment Trialists' Collaboration - 2015 - ses.library.usyd.edu.au
Background There has been debate about whether statin therapy is as effective in women
as men, especially for primary prevention. Methods Meta‐analyses were performed on data …
as men, especially for primary prevention. Methods Meta‐analyses were performed on data …
Hormone-replacement therapy: current thinking
RA Lobo - Nature Reviews Endocrinology, 2017 - nature.com
For several decades, the role of hormone-replacement therapy (HRT) has been debated.
Early observational data on HRT showed many benefits, including a reduction in coronary …
Early observational data on HRT showed many benefits, including a reduction in coronary …
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …
Surveys and registries are needed to verify that real-life daily practice is in kee** with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
CT Trialists - The Lancet, 2015 - Elsevier
Background Whether statin therapy is as effective in women as in men is debated, especially
for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol …
for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol …
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …
The guidelines for the ESC/EAS Guidelines for the management of dyslipidaemias produced
by the task force for the management of dyslipidaemias of the European Society of …
by the task force for the management of dyslipidaemias of the European Society of …
Interpretation of the evidence for the efficacy and safety of statin therapy
This Review is intended to help clinicians, patients, and the public make informed decisions
about statin therapy for the prevention of heart attacks and strokes. It explains how the …
about statin therapy for the prevention of heart attacks and strokes. It explains how the …
Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing
HN Hodis, WJ Mack - The Cancer Journal, 2022 - journals.lww.com
The totality of evidence indicates menopausal hormone replacement therapy (HRT) effects
are determined by timing of initiation according to age and/or time since menopause …
are determined by timing of initiation according to age and/or time since menopause …
Prevention of diseases after menopause
Women may expect to spend more than a third of their lives after menopause. Beginning in
the sixth decade, many chronic diseases will begin to emerge, which will affect both the …
the sixth decade, many chronic diseases will begin to emerge, which will affect both the …